ArticleScientific reports2025
Enhanced biocidal efficacy of alcohol based disinfectants with salt additives.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Assessing the persistence ofMicrobiology spectrum · 2026Article
- Article
- Rapid Multiplex Antimicrobial Resistance Profiling and Bacterial Identification by LAP-MALDI Mass Spectrometry Biotyping.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Food safety culture and the control of microbial communities in food production environments.npj antimicrobials and resistance · 2026Review
- Case Series of Bacteremia Associated with Probiotic Use in Children after Cardiac Surgery, China.Emerging infectious diseases · 2026Review
- Managing and monitoring indoor air quality and surface decontamination in healthcare environments.Arhiv za higijenu rada i toksikologiju · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Surfaces contaminated with pathogens pose a significant risk of disease transmission and infection. Alcohol-based disinfectants are widely utilized to decontaminate high-touch areas across various settings. However, their limited antimicrobial activity and the emergence of alcohol-tolerant strains necessitate the development of highly efficient disinfectant formulations. In this work we test the broad-spectrum antimicrobial activities of the salt-incorporated alcohol solution disinfectant against enveloped and non-enveloped viruses, spore-forming and non-spore-forming bacteria, and mold and yeast fungi. Specifically, the disinfection capability of the isopropanol (IPA) and ethanol (EtOH) solutions containing NaCl salts was evaluated by measuring (1) antibacterial activity against Gram-positive bacteria (methicillin-resistant Staphylococcus aureus), Gram-negative bacteria (Pseudomonas aeruginosa, Escherichia coli), and an alcohol-tolerant strain of E. coli; (2) sporicidal activity against Clostridioides difficile; (3) the antiviral activity against enveloped A/PR8/34 H1N1 influenza virus and non-enveloped adenovirus VR-5; and (4) the antifungal efficacy against Aspergillus niger and Cryptococcus neoformans from the time-dependent viability assays. Additionally, the biocidal activity of the disinfectant formulation was tested by spraying it on the biocontaminated surfaces, including plastics, stainless steel, and glass. Overall, the inclusion of salt in alcohol solutions significantly enhanced their disinfection activities, positioning these solutions as promising candidates for long-term disinfection and maintenance of hygienic environments. This method, which employs mild salt instead of toxic materials, offers a simpler, more cost-effective, and safer alternative to conventional alcohol-based disinfectants. This research is expected to significantly impact on disease prevention and contribute greatly to public health and safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.